Skip to content

High Flow Nasal Oxygen Versus Usual Care in COPD Pulmonary Rehabiliation

Comparing the Effect of High Flow Nasal Oxygen With Usual Care on Pulmonary Rehabilitation in COPD Patients After an Acute Exacerbation; a Pilot Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03940040
Enrollment
22
Registered
2019-05-07
Start date
2019-05-28
Completion date
2021-06-30
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

To compare the effects of high flow nasal oxygen with usual care during an outpatient 6-week pulmonary rehabilitation program after hospitalization for COPD exacerbation.

Detailed description

This is a pilot randomized controlled trial to compare the effects of high flow nasal oxygen with usual care during an outpatient 6-week pulmonary rehabilitation program after hospitalization for COPD exacerbation.

Interventions

OTHERUsual care

Usual Care

High flow nasal oxygen

Sponsors

Changi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 21 years and above 2. Known diagnosis of COPD based on history AND spirometry demonstrating post bronchodilator FEV1/FVC ratio \<0.7 3. Currently admitted inpatient for an acute COPD exacerbation as the primary diagnosis 4. Fit to participate in exercise therapy as determined by both physician and physiotherapist 5. Has the mental capacity to follow instructions 6. Experience shortness of breath on exertion 7. Have decreased ability to carry out activities due to shortness of breath 8. Willing to participate in the exercise program

Exclusion criteria

1. Uncontrolled/ unstable medical conditions such as severe chronic heart failure that make exercise unsafe 2. Pulmonary disorder other than COPD 3. Physical conditions that preclude the ability to participate in exercise or may impair exercise performance.

Design outcomes

Primary

MeasureTime frameDescription
6-minute walk distance6 weeksIt is the maximum distance walked in 6 minutes

Secondary

MeasureTime frameDescription
COPD Assessment Test score3 weeks, 6 weeks and 1 month after completion of programChronic obstructive pulmonary disease assessment test (CAT) score
Hospital Anxiety Depression Scale3 weeks, 6 weeks and 1 month after completion of programThis scale has 2 subscale scores of 1) Depression 2) Anxiety. Scores of 0-7 = Normal, 8-10 = Borderline, 11-21 = Abnormal
Respiratory function test3 weeks, 6 weeks and 1 month after completion of programIt is a test of respiratory function
6-minute walk distance3 weeks and 1 month after completion of programIt is the maximum distance walked in 6 minutes

Countries

Singapore

Contacts

Primary ContactYingjuan Mok, MBS
mok.yingjuan@singhealth.com.sg68502600
Backup ContactNur Shameerah Abdul Halim
Nur_Shameerah@cgh.com.sg68502600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026